Status:
COMPLETED
IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON ACQUIRED VACCINAL ANTI-SARS-CoV-2 ANTIBODIES.
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Therapeutic Plasma Exchange
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Context: Therapeutic plasma exchange is an extracorporeal blood purification technique that removes pathogenic substances (including antibodies) from plasma. This technique also combines an immunomod...
Detailed Description
Not provided
Eligibility Criteria
Inclusion
- Adult patients vaccinated against SARS-CoV-2 (any type of vaccine) and regularly receiving therapeutic plasma exchange in the adult hematology department of the Cliniques universitaires Saint Luc.
Exclusion
- Patients treated with therapeutic plasma exchange for an acute condition at the intensive care unit
- Patients unable to sign the ICF or unwilling to participate to the study
Key Trial Info
Start Date :
September 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05191394
Start Date
September 8 2021
End Date
February 1 2022
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques universitaires Saint-Luc
Brussels, International, Belgium, 1200